<DOC>
	<DOCNO>NCT02750800</DOCNO>
	<brief_summary>This study aim evaluate effect adalimumab patient support program ( PSP ) clinical , health economic , patient report outcomes patient rheumatoid arthritis , ankylose spondylitis , psoriatic arthritis , psoriasis , Crohn 's disease ulcerative colitis routine clinical setting Hungary .</brief_summary>
	<brief_title>Post-marketing Observational Study Evaluate Incremental Impact AbbVie 's Patient Support Program Patient Reported Outcomes Health Resource Utilization Inflammatory Arthritis , Psoriasis Inflammatory Bowel Diseases Hungary</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<criteria>Diagnosis RA , AS , PsA , Ps , CD UC treat physician . RA , AS , PsA , Ps , UC CD patient adalimumab treatment indicate per local Summary Product Characteristics ( SmPC ) professional/reimbursement guideline . Subjects assign adalimumab treatment 1 month prior inclusion . Patient participation AbbVie CARE 2.0 Patient Support Program ( PSP ) program offer patient decide join start PSP . Patients willing involved study sign patient inform consent form ( ICF ) subject information form ( SIF ) order allow use disclosure his/her personal health information . Patients treat adalimumab accord local adalimumab SmPC local professional reimbursement guideline . Patients treat &gt; 1 prior biologic DMARD RA , AS , PsA , Ps , UC CD . Prior treatment adalimumab 1 month . Patients currently participate clinical research . Patients unwilling unable complete quality life patient report questionnaire . Patients choose participate ABBVIE Care 2.0 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Patient relate outcome</keyword>
	<keyword>Psoriatic arthritis</keyword>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>Patient support program</keyword>
	<keyword>Ankylosing spondylitis</keyword>
	<keyword>Quality life</keyword>
	<keyword>Psoriasis</keyword>
	<keyword>Observational study</keyword>
	<keyword>Ulcerative colitis</keyword>
	<keyword>Crohn 's disease</keyword>
</DOC>